Epidemiology and Population Health

Recognizing those who go unseen – the impacts of fatal and non-fatal overdoses

August 31st is International Overdose Awareness Day, an annual campaign to end overdoses, remember without stigma those who have died from overdose, and acknowledge the grief of the family and friends left behind. The BC Centre for Excellence in HIV/AIDS (BC-CfE) joins families, friends and communities in mourning the needless losses of life through overdose and continue to advocate for an end to the toxic drug crisis through a safer supply of drugs.

Recognizing those who go unseen – the impacts of fatal and non-fatal overdoses Read More »

BC-CfE researchers examine HCV knowledge and awareness of reinfection risk among people successfully treated with direct acting antiviral therapy

The Hepatitis C virus (HCV) is a blood borne infection and a leading cause of end-stage liver disease. The World Health Organization estimates that about 58 million people are living with chronic HCV, leading to 290,000 deaths annually due to HCV-related liver illness. Here in Canada, HCV affects a quarter of a million people. Of this quarter million, over 40% are unaware of their infection.

BC-CfE researchers examine HCV knowledge and awareness of reinfection risk among people successfully treated with direct acting antiviral therapy Read More »

BC-CfE study examines how neighbourhood poverty affects those living with HIV

A recently published study by BC-CfE researchers titled Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort studyexamines the relationship between a neighbourhood’s socioeconomic status and how this affects the lives and health of Canadians living with HIV who are on combination antiretroviral therapy (ART).

BC-CfE study examines how neighbourhood poverty affects those living with HIV Read More »

Collaborative study examines COVID-19 vaccine immune responses in people living with HIV

BC Centre for Excellence in HIV/AIDS (BC-CfE) researchers, collaborating with counterparts at Simon Fraser University, the University of BC, Providence Health Care and the CIHR Canadian HIV Trials Network (CTN) recently published a study looking at COVID-19 vaccine immune responses in people living with HIV (PLWH). Due to the explosive growth of COVID-19 variants, and

Collaborative study examines COVID-19 vaccine immune responses in people living with HIV Read More »

Improving patient engagement and retention in healthcare at Hope to Health

A BC Centre for Excellence in HIV/AIDS (BC-CfE) research team is working to evaluate how a new primary care clinic can keep clients engaged in health care among residents of Vancouver’s Downtown East Side (DTES). The “Hope to Health Engagement and Retention Evaluation (HERE) Study” is being conducted from the Hope to Health (H2H) Research

Improving patient engagement and retention in healthcare at Hope to Health Read More »

BC-CfE’s Dr. Robert Hogg elected as a Fellow of the Royal Society of Canada

Senior Research Fellow at the BC-CfE and Distinguished Professor and Associate Dean of Research in the Faculty of Health Sciences at Simon Fraser University, Dr. Robert Hogg was recently elected as a Fellow of the Royal Society of Canada (RSC) for 2021. This recognition by the RSC for career achievement ranks among the highest academic honours for a Canadian.

BC-CfE’s Dr. Robert Hogg elected as a Fellow of the Royal Society of Canada Read More »